These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 37577321)
21. Development and validation of polyamines metabolism-associated gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma. Wang N; Chai M; Zhu L; Liu J; Yu C; Huang X Front Immunol; 2023; 14():1070953. PubMed ID: 37334367 [TBL] [Abstract][Full Text] [Related]
22. Construction of a prognostic model for lung adenocarcinoma based on membrane-tension-related genes. Zhu P; Teng Z; Yang W; Zhang D; Wang B; Yang Z; Wang K; Pu J J Thorac Dis; 2023 Apr; 15(4):2098-2115. PubMed ID: 37197492 [TBL] [Abstract][Full Text] [Related]
23. Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma. Xu ZY; Zhao M; Chen W; Li K; Qin F; Xiang WW; Sun Y; Wei J; Yuan LQ; Li SK; Lin SH PeerJ; 2020; 8():e9530. PubMed ID: 32775050 [TBL] [Abstract][Full Text] [Related]
24. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma. Wu P; Zheng Y; Wang Y; Wang Y; Liang N J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329 [TBL] [Abstract][Full Text] [Related]
25. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
26. Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma. Jia H; Tang WJ; Sun L; Wan C; Zhou Y; Shen WZ Front Genet; 2022; 13():1017866. PubMed ID: 36699466 [No Abstract] [Full Text] [Related]
27. Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes. Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S Cancer Cell Int; 2021 Apr; 21(1):219. PubMed ID: 33858449 [TBL] [Abstract][Full Text] [Related]
28. Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma. Xu Y; Tao T; Li S; Tan S; Liu H; Zhu X Front Genet; 2022; 13():975905. PubMed ID: 36313456 [No Abstract] [Full Text] [Related]
29. Development of a copper metabolism-related gene signature in lung adenocarcinoma. Chang W; Li H; Zhong L; Zhu T; Chang Z; Ou W; Wang S Front Immunol; 2022; 13():1040668. PubMed ID: 36524120 [TBL] [Abstract][Full Text] [Related]
30. Identification of a Five Autophagy Subtype-Related Gene Expression Pattern for Improving the Prognosis of Lung Adenocarcinoma. Zhang MY; Huo C; Liu JY; Shi ZE; Zhang WD; Qu JJ; Yue YL; Qu YQ Front Cell Dev Biol; 2021; 9():756911. PubMed ID: 34869345 [No Abstract] [Full Text] [Related]
31. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies. Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089 [TBL] [Abstract][Full Text] [Related]
32. An Han Y; Wong FC; Wang D; Kahlert C Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555 [TBL] [Abstract][Full Text] [Related]
33. Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma. Zeng W; Wang J; Yang J; Chen Z; Cui Y; Li Q; Luo G; Ding H; Ju S; Li B; Chen J; Xie Y; Tong X; Liu M; Zhao J Front Immunol; 2023; 14():1217590. PubMed ID: 37492563 [TBL] [Abstract][Full Text] [Related]
34. A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD). Al-Dherasi A; Huang QT; Liao Y; Al-Mosaib S; Hua R; Wang Y; Yu Y; Zhang Y; Zhang X; Huang C; Mousa H; Ge D; Sufiyan S; Bai W; Liu R; Shao Y; Li Y; Zhang J; Shi L; Lv D; Li Z; Liu Q Cancer Cell Int; 2021 Jun; 21(1):294. PubMed ID: 34092242 [TBL] [Abstract][Full Text] [Related]
35. A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma. Yang X; Wang G; Gu R; Xu X; Zhu G PeerJ; 2020; 8():e10418. PubMed ID: 33304656 [TBL] [Abstract][Full Text] [Related]
36. Vesicle-mediated transport-related genes are prognostic predictors and are associated with tumor immunity in lung adenocarcinoma. Qian C; Jiang Z; Zhou T; Wu T; Zhang Y; Huang J; Ouyang J; Dong Z; Wu G; Cao J Front Immunol; 2022; 13():1034992. PubMed ID: 36524130 [TBL] [Abstract][Full Text] [Related]
37. Identification of a novel autophagy signature for predicting survival in patients with lung adenocarcinoma. Duan J; Lei Y; Lv G; Liu Y; Zhao W; Yang Q; Su X; Song Z; Lu L; Shi Y PeerJ; 2021; 9():e11074. PubMed ID: 33976960 [TBL] [Abstract][Full Text] [Related]
38. Systematic Analysis and Identification of Molecular Subtypes of TRP-Related Genes and Prognosis Prediction in Lung Adenocarcinoma. Guo Y; Liu N J Oncol; 2022; 2022():5388283. PubMed ID: 36090899 [TBL] [Abstract][Full Text] [Related]
39. Construction of a prognostic model for lung adenocarcinoma based on bioinformatics analysis of metabolic genes. He J; Li W; Li Y; Liu G Transl Cancer Res; 2020 May; 9(5):3518-3538. PubMed ID: 35117717 [TBL] [Abstract][Full Text] [Related]
40. A novel pyroptosis-related prognostic signature for lung adenocarcinoma: Identification and multi-angle verification. Wang X; Zhou J; Li Z; Chen X; Wei Q; Chen K; Jiang R Front Genet; 2023; 14():1160915. PubMed ID: 37077542 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]